Hsa_circ_0072309 enhances autophagy and TMZ sensitivity in glioblastoma
- PMID: 35212145
- PMCID: PMC9062556
- DOI: 10.1111/cns.13821
Hsa_circ_0072309 enhances autophagy and TMZ sensitivity in glioblastoma
Abstract
Aims: Circular RNAs have been reported to play key roles in the progression of various cancers, including gliomas. The present study was designed to investigate the role of hsa_circ_0072309 in autophagy and temozolomide (TMZ) sensitivity in glioblastoma (GBM).
Methods: The effect of hsa_circ_0072309 on autophagy and TMZ sensitivity were examined by GFP-RFP-LC3, transmission electron microscopy(TEM), flow cytometry, Western blot, and immunofluorescence. The mechanism of hsa_circ_0072309 regulating p53 signaling pathway was analyzed using Western blot, IP, and rescue experiments.
Results: Low hsa_circ_0072309 expression predicts poor prognosis for glioma patients. The regulation of hsa_circ_0072309 on autophagy and TMZ sensitivity depends on the status of p53. Hsa_circ_0072309 promoted autophagy by p53 signaling pathway and enhanced sensitivity of glioblastoma to temozolomide (TMZ) in p53 wild-type GBM, but not in p53 mutant GBM. Hsa_circ_0072309 inhibits p53 ubiquitination and increases the stability of p53 protein in the context of p53 wild-type. MiR-100 mediates hsa_circ_0072309 regulating p53. P53 inhibitor or autophagy inhibitor could reverse the effect of hsa_circ_0072309 on TMZ sensitivity in p53 wild-type GBM.
Conclusions: This study revealed a function of hsa_circ_0072309 promoting autophagy by p53 signaling pathway and enhancing TMZ sensitivity. These findings demonstrated that hsa_circ_0072309 may be a potential and promising target in designing the treatment strategy for GBM.
Keywords: autophagy; circRNA; glioblastoma; temozolomide.
© 2022 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures








Similar articles
-
Hsa_circ_0043949 reinforces temozolomide resistance via upregulating oncogene ITGA1 axis in glioblastoma.Metab Brain Dis. 2022 Dec;37(8):2979-2993. doi: 10.1007/s11011-022-01069-3. Epub 2022 Oct 27. Metab Brain Dis. 2022. PMID: 36301458
-
Downregulation of hsa_circ_0000936 sensitizes resistant glioma cells to temozolomide by sponging miR-1294.J Biosci. 2020;45:101. J Biosci. 2020. PMID: 32975228
-
Hsa_circ_0110757 upregulates ITGA1 to facilitate temozolomide resistance in glioma by suppressing hsa-miR-1298-5p.Cell Death Dis. 2021 Mar 5;12(3):252. doi: 10.1038/s41419-021-03533-x. Cell Death Dis. 2021. PMID: 33674567 Free PMC article.
-
MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma.Mol Brain. 2024 Jul 2;17(1):42. doi: 10.1186/s13041-024-01113-6. Mol Brain. 2024. PMID: 38956588 Free PMC article. Review.
-
Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance.Cells. 2024 Aug 11;13(16):1332. doi: 10.3390/cells13161332. Cells. 2024. PMID: 39195222 Free PMC article. Review.
Cited by
-
CircSOBP suppresses the progression of glioma by disrupting glycolysis and promoting the MDA5-mediated immune response.iScience. 2023 Sep 13;26(10):107897. doi: 10.1016/j.isci.2023.107897. eCollection 2023 Oct 20. iScience. 2023. PMID: 37766977 Free PMC article.
-
LncRNA LINC01018/miR-942-5p/KNG1 axis regulates the malignant development of glioma in vitro and in vivo.CNS Neurosci Ther. 2023 Feb;29(2):691-711. doi: 10.1111/cns.14053. Epub 2022 Dec 22. CNS Neurosci Ther. 2023. PMID: 36550594 Free PMC article.
-
The potential role and mechanism of circRNAs in foam cell formation.Noncoding RNA Res. 2023 Mar 21;8(3):315-325. doi: 10.1016/j.ncrna.2023.03.005. eCollection 2023 Sep. Noncoding RNA Res. 2023. PMID: 37032721 Free PMC article. Review.
-
Regulation of autophagy by non-coding RNAs in human glioblastoma.Med Oncol. 2024 Oct 7;41(11):260. doi: 10.1007/s12032-024-02513-3. Med Oncol. 2024. PMID: 39375229 Review.
-
The regulatory role and clinical application prospects of circRNA in the occurrence and development of CNS tumors.CNS Neurosci Ther. 2024 Apr;30(4):e14500. doi: 10.1111/cns.14500. Epub 2023 Nov 12. CNS Neurosci Ther. 2024. PMID: 37953502 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous